Biotech

All Articles

Repare lays off 25% of personnel as biotech standstills preclinical R&ampD

.Repare Therapeutics is laying off a fourth of its staff as the oncology biotech downsize its precli...

J &amp J files for FDA permission of $6.5 B autoimmune medicine

.Johnson &amp Johnson has gotten another step towards recognizing a gain on its own $6.5 billion nip...

Gain's phase 1 win paves way to confirm Parkinson's medicine's worth

.Gain Therapeutics has actually specified its own direct showing the performance of its Parkinson's ...

Actinogen reports new stage 2 records to recover depression drug

.Actinogen Medical's hopes-- as well as supply cost-- have actually recoiled somewhat from previousl...

Pfizer and also Crown jewel add Quotient to multibillion-dollar formula

.Flagship Pioneering and Pfizer have actually added Ratio into their 10-program collaboration, inkin...

Bayer markers $547M contract to press boundaries of noncoding RNA

.Bayer execs were keen to anxiety to Ferocious this summer that the German pharma giant's cravings f...

UK introduces plans to introduce 18 new scientific trial centers

.Amidst a yearslong medical test downtrend in the U.K., a new public-private relationship has actual...

UPDATE: Genentech telegrams 93 discharges in California after discussing strategies to shutter cancer cells immunology research device

.Following the statement of a sizable layoff round in April as well as a primary rebuilding effort i...

Neurocrine's KarXT rival hits in stage 2-- yet merely at low dose

.Neurocrine Biosciences has attained its hoped-for profile page in a stage 2 schizophrenia test, del...

Vaderis' rare capillary problem medicine minimizes nosebleeds

.Vaderis Therapeutics' goal to cultivate the very first medicine intended specifically at a specific...